Bertrand TOMBAL
Bertrand TOMBAL
Cliniques universitaires Saint Luc
Verified email at - Homepage
Cited by
Cited by
Enzalutamide in metastatic prostate cancer before chemotherapy
TM Beer, AJ Armstrong, DE Rathkopf, Y Loriot, CN Sternberg, CS Higano, ...
New England Journal of Medicine 371 (5), 424-433, 2014
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
MR Smith, F Saad, R Coleman, N Shore, K Fizazi, B Tombal, K Miller, ...
The Lancet 379 (9810), 39-46, 2012
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
M Bolla, H van Poppel, B Tombal, K Vekemans, L Da Pozzo, ...
The Lancet 380 (9858), 2018-2027, 2012
Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting
L Dickinson, HU Ahmed, C Allen, JO Barentsz, B Carey, JJ Futterer, ...
European urology 59 (4), 477-494, 2011
Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ...
European urology 73 (2), 178-211, 2018
Adverse effects of androgen deprivation therapy and strategies to mitigate them
PL Nguyen, SMH Alibhai, S Basaria, AV D’Amico, PW Kantoff, NL Keating, ...
European urology 67 (5), 825-836, 2015
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer …
M Guckenberger, Y Lievens, AB Bouma, L Collette, A Dekker, MS Nandita, ...
The Lancet Oncology 21 (1), e18-e28, 2020
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C Parker, E Castro, K Fizazi, A Heidenreich, P Ost, G Procopio, B Tombal, ...
Annals of Oncology 31 (9), 1119-1134, 2020
Prevention and early detection of prostate cancer
J Cuzick, MA Thorat, G Andriole, OW Brawley, PH Brown, Z Culig, ...
The lancet oncology 15 (11), e484-e492, 2014
Cabazitaxel versus abiraterone or enzalutamide in metastatic prostate cancer
R de Wit, J de Bono, CN Sternberg, K Fizazi, B Tombal, C Wülfing, ...
New England Journal of Medicine 381 (26), 2506-2518, 2019
Darolutamide and survival in metastatic, hormone-sensitive prostate cancer
MR Smith, M Hussain, F Saad, K Fizazi, CN Sternberg, ED Crawford, ...
New England Journal of Medicine 386 (12), 1132-1142, 2022
Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of …
CL Vale, S Burdett, LHM Rydzewska, L Albiges, NW Clarke, D Fisher, ...
The lancet oncology 17 (2), 243-256, 2016
Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guerin, and …
RJ Sylvester, MA Brausi, WJ Kirkels, W Hoeltl, FC Da Silva, PH Powell, ...
European urology 57 (5), 766-773, 2010
Enzalutamide in men with chemotherapy-naive metastatic castration-resistant prostate cancer: extended analysis of the phase 3 PREVAIL study
TM Beer, AJ Armstrong, D Rathkopf, Y Loriot, CN Sternberg, CS Higano, ...
European urology 71 (2), 151-154, 2017
Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical …
A Bex, P Mulders, M Jewett, J Wagstaff, JV Van Thienen, CU Blank, ...
JAMA oncology 5 (2), 164-170, 2019
Metastasis-free survival is a strong surrogate of overall survival in localized prostate cancer
W Xie, MM Regan, M Buyse, S Halabi, PW Kantoff, O Sartor, H Soule, ...
Journal of Clinical Oncology 35 (27), 3097, 2017
Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist
PC Albertsen, L Klotz, B Tombal, J Grady, TK Olesen, J Nilsson
European urology 65 (3), 565-573, 2014
Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes
WC Au, PA Moore, DW LaFleur, B Tombal, PM Pitha
Journal of Biological Chemistry 273 (44), 29210-29217, 1998
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
S Gillessen, A Omlin, G Attard, JS De Bono, E Efstathiou, K Fizazi, ...
Annals of Oncology 26 (8), 1589-1604, 2015
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised …
M Smith, C Parker, F Saad, K Miller, B Tombal, QS Ng, M Boegemann, ...
The Lancet Oncology 20 (3), 408-419, 2019
The system can't perform the operation now. Try again later.
Articles 1–20